Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed17f66ab9461b49d0ad6c1088d8747b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3841fc782c3fa6a0bb14960b6ebc2685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce03f89c6d9f6f5ef62664aebdae462b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18472f143d5f75bd40eac8cbf7d50de2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b869e02ac2f2e329e0ef209fdff057f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f8dfe935f0b529361d936bda59103eb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-043 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
filingDate |
2006-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3144651642741bcb68ab4f0d983b14c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f716eed85d66e16b864a6fc247376f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ac11645e9a7efe31342d4cadbf5859a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29d60515a92ea5b1f1837fd071088fe0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5da6bfb2990fa0511145729b1fa9061d |
publicationDate |
2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2007062469-A1 |
titleOfInvention |
Methods and compositions for preventing and/or treating pancreatitis |
abstract |
The present invention relates to a method of preventing and/or treating pancreatitis in a subject, the method including administering to the subject a therapeutically effective amount of a Galanin antagonist and/or a Galanin receptor antagonist. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010254645-A |
priorityDate |
2005-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |